WAY 195725
Alternative Names: WAY-195725Latest Information Update: 10 Aug 2009
At a glance
- Originator Wyeth
- Class Antirheumatics
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Dysmenorrhoea; Osteoarthritis; Rheumatoid arthritis
Most Recent Events
- 10 Aug 2009 Discontinued - Phase-I for Dysmenorrhoea in USA (PO)
- 10 Aug 2009 Discontinued - Phase-I for Osteoarthritis in USA (PO)
- 10 Aug 2009 Discontinued - Phase-I for Rheumatoid arthritis in USA (PO)